---
$id: https://graph.org.ai/products/commodity/51142538
$type: Product
source: UNSPSC
code: "51142538"
title: "Rotigotine"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rotigotine

**UNSPSC Code**: 51142538
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist with the molecular formula C19H25NOS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 87T4T8BO2E, chemically known as 6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol but generally known as rotigotine, which bears US NIH Compound Identifier 57537. European Medicines Agency schedules Rotigotine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21254. The term ROTIGOTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 1, 2001, List 45). World Health Organization schedules rotigotine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule rotigotine under HS 29349990 and SITC 51579. As of Q4 2014, ROTIGOTINE remains the US FDA Preferred Term for this commodity. Rotigotine bears US NLM identifiers UMLS ID C1700683 and NCI Concept Code C77566. SMILES: S1C(CCN(C2CCC3C(C2)CCCC3O)CCC)CCC1.

